European people with cystic fibrosis carrying A1006E mutation

Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation


Autores: Pedro Mondejar-Lopez, Anna Zolin, Patricia W Garcia-Marcos, Mª Dolores Pastor-Vivero, Maria Rosa-Silvestre, Francisco de Asis Sanchez-Martinez, Donatello Salvatore, Giuseppe Cimino, Fabio Majo, Amparo Sole-Jover, Oscar Asensio de la Cruz, Maria Adelaide Calderazzo, Giovanna Pizzamiglio, Silvia Castillo-Corullon, Antonio Alvarez-Fernandez, Silvia Gartner, Rita Padoan, Vincenzo Carnovale, Marco Salvatore, Mª Rosa Moya-Quiles, Annalisa Orenti, Guillermo Glover, Manuel Sanchez-Solis


Background: A1006E is a Cystic Fibrosis (CF) mutation that is still not widely known. We report phenotypic features and geographic distribution of the largest cohort of people with CF (pwCF) carrying A1006E to date.

Methods: Study of European pwCF carrying A1006E mutation, included in the European CF Society Patient Registry (ECFSPR). Genotype, ancestries and all variables recorded were compared to a cohort of F508del/F508del patients. Rate of decline in percentage-of-predicted FEV1 (ppFEV1) was also analyzed using the 2010-2017 ECFSPR.

Results: 44 pwCF carrying A1006E were reported (59% males), median age 33 years old (3-58), 54.5% Spanish and 40.9% Italian, most with ancestry in Murcia (Spain) and Lazio (Italy) regions. Compared to F508del homozygous, A1006E-pwCF were significantly older (75% vs. 52.5% ≥ 18 years old) and diagnosed at later median age (6.98 vs. 0.29 years); showed lower rates of meconium ileus (2.33% vs. 17.7%), pancreatic insufficiency (27.91% vs. 99.26%), diabetes (2.33% vs. 21.98%), liver disease (6.98% vs. 36.72%) and Pseudomonas aeruginosa chronic colonization (30.95% vs. 42.51%); and presented better nutrition (BMI z-score 0.44 vs. -0.43) and ppFEV1 (90.8% vs. 78.6%), with 18.9% (most >40 years old) having a ppFEV1<70%. Additional ppFEV1 decline (0.96% per year) was attributed to F508del/F508del genotype (p = 0.0007). None died or needed organ transplantation during the study period. Conclusions: A1006E-pwCF are mainly of Western Mediterranean Spanish and Italian descent. When compared with F508del/F508del-pwCF, they usually have a milder form of the disease, associated with pancreatic sufficiency and slower FEV1 decline. However, some will develop progressive respiratory impairment during adulthood.

Referencia formato Vancouver:

Respir Med. 2022 Feb;192:106736. doi: 10.1016/j.rmed.2022.106736. Epub 2022 Jan 6. PMID: 35032736 DOI: 10.1016/j.rmed.2022.106736

Referencia electrónica

https://doi.org/10.1016/j.rmed.2022.106736

Who is Manu Novillo

You need update your bio: Edita el perfil

Deja una respuesta

Tu email no será publicado Required fields are marked *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.

BACK

Este sitio web utiliza cookies para facilitar y mejorar tu navegación. Por favor, acepta la utilización de las cookies de este sitio web. Para más información, puedes consultar nuestra Política de Privacidad y Tratamiento de Datos y Política de Cookies Política de Privacidad y Tratamiento de Datos y Política de Cookies

Los ajustes de cookies en esta web están configurados para «permitir las cookies» y ofrecerte la mejor experiencia de navegación posible. Si sigues usando esta web sin cambiar tus ajustes de cookies o haces clic en «Aceptar», estarás dando tu consentimiento a esto.

Cerrar